ArticleCNS neuroscience & therapeutics2026
Genetic Association of Sexual Behavior, Sildenafil, and Hormonal Contraceptives With Mental Disorders.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe observational research indicates that risky sexual activities contribute to the development of mental disorders. However, the potential causal effects of sexual behaviors, sildenafil use, and hormonal contraceptive use on mental disorders remain unclear.
methodsWe applied two-sample Mendelian randomization (univariable and multivariable MR) to assess the effects of age at first sex (AFS) and number of sexual partners (NSP) on mental disorders and sex differences, using Genome-Wide Association Studies (GWAS) data from UK Biobank and FinnGen. An observational analysis using NHANES 2015-2016 was conducted for validation. We further used expression quantitative trait loci (eQTL) to proxy drug target genes and examined the impact of sildenafil and contraceptives on mental disorders using SMR and IVW-MR methods.
resultsWe found that an increased genetically predicted AFS was associated with decreasing anxiety disorders, bipolar affective disorders, depression, disturbance of activity and attention (DAA), and post-traumatic stress disorder. An increased genetically predicted NSP was associated with increasing anxiety disorders, bipolar affective disorders, depression, and post-traumatic stress disorder. SMR analysis found that PDE11A, instead of PDE5A, a drug target for sildenafil, causes DAA. Suggestive evidence was observed regarding the positive association between progesterone receptor expression and risk of depression. Notably, given the exploratory nature of the multiple analyses, these findings require replication in independent cohorts to confirm causal relationships.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.